Does SPIRONOLACTONE Cause Diffuse large b-cell lymphoma refractory? 43 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Diffuse large b-cell lymphoma refractory have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.2% of all adverse event reports for SPIRONOLACTONE.
43
Reports of Diffuse large b-cell lymphoma refractory with SPIRONOLACTONE
0.2%
of all SPIRONOLACTONE reports
0
Deaths
43
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From SPIRONOLACTONE?
Of the 43 reports, 43 (100.0%) required hospitalization.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does SPIRONOLACTONE Cause?
Acute kidney injury (3,273)
Hyperkalaemia (2,518)
Hypotension (1,583)
Dyspnoea (1,468)
Drug ineffective (1,379)
Hyponatraemia (1,166)
Dizziness (991)
Fatigue (990)
Fall (947)
Off label use (899)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which SPIRONOLACTONE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
SPIRONOLACTONE vs SPRYCEL
SPIRONOLACTONE vs STALEVO
SPIRONOLACTONE vs STANNOUS FLUORIDE
SPIRONOLACTONE vs STANOZOLOL
SPIRONOLACTONE vs STAVUDINE